Celator Pharmaceuticals Inc. (NASDAQ:CPXX) Posted Basic Consolidated EPS Of $-0.5689

0

Celator Pharmaceuticals Inc. (NASDAQ:CPXX) annual basic consolidated EPS was $-0.5689 for the period ended 2015-12-31. The basic consolidated EPS was $-0.5689 for the quarter ended 2015-12-31.

EPS from continuing operations

Celator Pharmaceuticals Inc. (NASDAQ:CPXX)’s basic EPS from continuing operations was $-0.5689 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-0.5689

EPS contribution from parent

From the parent company Celator Pharmaceuticals Inc. (NASDAQ:CPXX) posted basic EPS of $-0.5689 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-0.5689.

Basic net EPS

The Basic net EPS of Celator Pharmaceuticals Inc. (NASDAQ:CPXX) was $-0.57 for the period ended 2015-12-31. The figure stood at $-0.57 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-0.5689. While the figure for the quarter ended 2015-12-31 stood at $-0.5689.

Basic diluted EPS

The diluted EPS from continuing operation of Celator Pharmaceuticals Inc. (NASDAQ:CPXX) stood at $-0.5689 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.5689

Net diluted EPS

The Net diluted EPS was $-0.57 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.57.

Diluted EPS from parent

Celator Pharmaceuticals Inc. (NASDAQ:CPXX) diluted EPS from the parent company for the fiscal 2015-12-31 was $-0.5689. The figure for the quarter ended 2015-12-31 was $-0.5689

The net basic EPS was $-0.57 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-0.57

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)